Eli Lilly gets FDA approval for new obesity drug
November 08, 2023 at 13:22 PM EST
Zepbound helped patients lose up to 48 pounds on average in clinical trials.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|